Biochemical and Structural Insights into Carbonic Anhydrase XII/Fab6A10 Complex

Volume: 431, Issue: 24, Pages: 4910 - 4921
Published: Dec 1, 2019
Abstract
6A10 is a CA XII inhibitory monoclonal antibody, which was demonstrated to reduce the growth of cancer cells in vitro and in a xenograft model of lung cancer. It was also shown to enhance chemosensitivity of multiresistant cancer cell lines and to significantly reduce the number of lung metastases in combination with doxorubicin in mice carrying human triple-negative breast cancer xenografts. Starting from these data, we report here on the...
Paper Details
Title
Biochemical and Structural Insights into Carbonic Anhydrase XII/Fab6A10 Complex
Published Date
Dec 1, 2019
Volume
431
Issue
24
Pages
4910 - 4921
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.